Jerusalem, 5 November, 2025 (TPS-IL) — Israeli medical technology company FIZE Medical has secured an investment and distribution deal with Eldan, a member of Israel’s Neopharm Group, to expand its presence in Israel. Eldan will invest in FIZE Medical and act as the exclusive distributor of its smart fluid management solutions for critically ill patients across the country.
FIZE Medical’s flagship FIZE kUO system, already used in leading hospitals worldwide, has monitored over 20,000 patients. The partnership is expected to strengthen Israel’s role in advanced ICU technologies, with both companies highlighting the potential to improve patient outcomes and accelerate global commercialization from a local base.